Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

Koji Kato; Yoshihiro Inamoto; Toshiro Kawakita; Yasushi Onishi; Ken Ichi Matsuoka; Soichi Shiratori; Kazuhiro Ikegame; Nobuhiro Hiramoto; Masako Toyosaki; Yuta Katayama; Yuhki Koga; Shun Murayama; Yuji Sasagawa; Mami Shindo; Takanori Teshima; Kiyohiko Hatake; Yoshinobu Maeda

doi:10.1038/s41409-025-02775-z

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

Koji Kato
, Yoshihiro Inamoto
, Toshiro Kawakita
, Yasushi Onishi
, Ken Ichi Matsuoka
, Soichi Shiratori
, Kazuhiro Ikegame
, Nobuhiro Hiramoto
, Masako Toyosaki
, Yuta Katayama
, Yuhki Koga
, Shun Murayama
, Yuji Sasagawa
, Mami Shindo
, Takanori Teshima
, Kiyohiko Hatake
, Yoshinobu Maeda

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	225-228
ページ数	4
ジャーナル	Bone Marrow Transplantation
巻	61
号	2
DOI	https://doi.org/10.1038/s41409-025-02775-z
出版ステータス	出版済み - 02-2026
外部発表	はい

All Science Journal Classification (ASJC) codes

血液学
移植

文献へのアクセス

10.1038/s41409-025-02775-z

他のファイルとリンク

引用スタイル

Kato, K., Inamoto, Y., Kawakita, T., Onishi, Y., Matsuoka, K. I., Shiratori, S., Ikegame, K., Hiramoto, N., Toyosaki, M., Katayama, Y., Koga, Y., Murayama, S., Sasagawa, Y., Shindo, M., Teshima, T., Hatake, K., & Maeda, Y. (2026). Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study. Bone Marrow Transplantation, 61(2), 225-228. https://doi.org/10.1038/s41409-025-02775-z

@article{d31cdf67e78a443383a3aa494b4cb740,

title = "Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study",

author = "Koji Kato and Yoshihiro Inamoto and Toshiro Kawakita and Yasushi Onishi and Matsuoka, \{Ken Ichi\} and Soichi Shiratori and Kazuhiro Ikegame and Nobuhiro Hiramoto and Masako Toyosaki and Yuta Katayama and Yuhki Koga and Shun Murayama and Yuji Sasagawa and Mami Shindo and Takanori Teshima and Kiyohiko Hatake and Yoshinobu Maeda",

year = "2026",

month = feb,

doi = "10.1038/s41409-025-02775-z",

language = "English",

volume = "61",

pages = "225--228",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "2",

}

Kato, K, Inamoto, Y, Kawakita, T, Onishi, Y, Matsuoka, KI, Shiratori, S, Ikegame, K, Hiramoto, N, Toyosaki, M, Katayama, Y, Koga, Y, Murayama, S, Sasagawa, Y, Shindo, M, Teshima, T, Hatake, K & Maeda, Y 2026, 'Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study', Bone Marrow Transplantation, vol. 61, no. 2, pp. 225-228. https://doi.org/10.1038/s41409-025-02775-z

TY - JOUR

T1 - Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD

T2 - clinical outcomes from a Japanese study

AU - Kato, Koji

AU - Inamoto, Yoshihiro

AU - Kawakita, Toshiro

AU - Onishi, Yasushi

AU - Matsuoka, Ken Ichi

AU - Shiratori, Soichi

AU - Ikegame, Kazuhiro

AU - Hiramoto, Nobuhiro

AU - Toyosaki, Masako

AU - Katayama, Yuta

AU - Koga, Yuhki

AU - Murayama, Shun

AU - Sasagawa, Yuji

AU - Shindo, Mami

AU - Teshima, Takanori

AU - Hatake, Kiyohiko

AU - Maeda, Yoshinobu

PY - 2026/2

Y1 - 2026/2

UR - https://www.scopus.com/pages/publications/105023075440

UR - https://www.scopus.com/pages/publications/105023075440#tab=citedBy

U2 - 10.1038/s41409-025-02775-z

DO - 10.1038/s41409-025-02775-z

M3 - Letter

C2 - 41298855

AN - SCOPUS:105023075440

SN - 0268-3369

VL - 61

SP - 225

EP - 228

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 2

ER -